In Reply
- 10 February 2007
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (5) , e3-e5
- https://doi.org/10.1200/jco.2006.08.5100
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Platelet-derived growth factor receptor-β in Gorham's diseaseNature Clinical Practice Oncology, 2006
- Differential CD146 Expression on Circulating Versus Tissue Endothelial Cells in Rectal Cancer Patients: Implications for Circulating Endothelial and Progenitor Cells As Biomarkers for Antiangiogenic TherapyJournal of Clinical Oncology, 2006
- Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in CancerNeoplasia, 2006
- Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparisonThrombosis and Haemostasis, 2006
- Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer PatientsJournal of Clinical Oncology, 2005
- CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral bloodBlood, 2005
- Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometryCytometry Part B: Clinical Cytometry, 2005
- Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord bloodBlood, 2004
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNature Medicine, 2004
- Resting and activated endothelial cells are increased in the peripheral blood of cancer patientsBlood, 2001